Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 3, 2000 - Issue 4
Journal homepage
30
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Medical costs of intravascular ultrasound optimization of stent deployment. Results of the multicenter randomized 'REStenosis after Intravascular ultrasound STenting' (RESIST) study

François Schiele Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
,
Nicolas Meneveau Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
,
Marie-France Seronde Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
,
Fiona Caulfield Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
,
Béatrice Pisa Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
,
Patrick Arveux Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
,
Bernard Bertrand Hôpital Michallon Service de Cardiologie Grenoble
,
Nicolas Danchin Hôpital de Brabois Service de Cardiologie A Vandoeuvre les Nancy France
&
Jean-Pierre Bassand Hôpital Universitaire Jean-Minjoz Service de Cardiologie Besançon
 show all
Pages 207-213 | Published online: 10 Jul 2009

  • Baim DS, Leon MB, Popma JJ, et al. Problems in the evaluation of new devices for coronary intervention: what have we learned since 1989? Am J Cardiol 1997; 80: 3K-9K.
  • van Hout B, van der Woude T, de Jaegere P, et al. Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience. Semin Intervent Cardiol 1996; 1: 263-268.
  • Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 1998; 352: 673-681.
  • Peterson ED, Cowper PA, DeLong ER, Zidar JP, Stack RS, Mark DB. Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 1999; 33: 1610-1618.
  • Weintraub WS, Culler S, Boccuzzi SJ, et al. Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. J Am Coll Cardiol 1999; 34: 1061-1066.
  • de Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographie results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 1998; 19: 1214-1223.
  • Schiele F, Meneveau N, Vuillemenot A, et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies-with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guided STenting. J Am Coll Cardiol 1998; 32: 320-328.
  • Fitzgerald PJ, Oshima A, Hayase M, et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 2000; 102: 523-530.
  • Nakamura S, Columbo A, Gaglione A. Intracoronary ultrasound observations during stent implantation. Circulation 1994; 89:2026-2034.
  • Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688.
  • Akiyama T, Moussa I, Reimers B, et al. Angiographie and clinical outcome following coronary stenting of small vessels: a comparison with coronaiy stenting of large vessels. J Am Coll Cardiol 1998; 32: 1610-1618.
  • Cohen DJ. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluation of the cost-effectiveness of coronary stenting: a societal perspective. Am Heart) 1999; 137:5138-5141.
  • Sukin CA, Baim DS, Caputo RP, et al. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol 1997; 79: 275-280.
  • Topol EJ. Coronary angioplasty for acute myocardial infarction. Ann Intern Med 1988; 109: 970-980.
  • Van Hout B, Simmons M. Costs and effects of c7E3 in high risk FTCA patients. An indirect analysis for the Netherlands. Eur Heart J 1999;16 (suppl):81-85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.